Ashland (ASH) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ashland (ASH) Beats Q1 Earnings Estimates
Ashland (ASH) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.28 per share a year ago.
Lyell Immunopharma: LYL314 Drives Momentum Amid Strong ASH Data
Lyell Immunopharma (LYEL) has surged 191% YTD, driven by strong momentum and promising CAR T-cell therapy pipeline candidates LYL314 and LYL273. LYL314 achieved a 93% overall response and 76% complete response rate in heavily pre-treated LBCL, positioning LYEL as a differentiated player in CAR T therapies. LYEL maintains a $320 million cash position, funding operations into 2027, with pivotal LYL314 trial data and a BLA submission targeted for 2027.
Ashland (ASH) Up 14.9% Since Last Earnings Report: Can It Continue?
Ashland (ASH) reported earnings 30 days ago. What's next for the stock?
Ashland Q4 Earnings Miss Estimates on Portfolio Actions, Revenues Down
ASH posts higher Q4 profit but weaker adjusted earnings as sales fall across key segments amid portfolio shifts.
Ashland (ASH) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Ashland (ASH) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ashland (ASH) Q4 Earnings Lag Estimates
Ashland (ASH) came out with quarterly earnings of $1.08 per share, missing the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.26 per share a year ago.
Analysts Estimate Ashland (ASH) to Report a Decline in Earnings: What to Look Out for
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Ashland Stock?
Investors need to pay close attention to ASH stock based on the movements in the options market lately.
Ashland Q3 Earnings and Sales Lag Estimates, Guidance Narrowed
ASH posts a third-quarter loss of $742 million and misses on sales as portfolio cuts weigh. Full-year guidance range is narrowed.
Ashland Inc. (ASH) Q3 2025 Earnings Call Transcript
Ashland Inc. (NYSE:ASH ) Q3 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Alessandra Faccin Assis - Senior VP and GM of Life Sciences & Intermediates Dago Caceres - SVP & General Manager of Specialty Additives Guillermo Novo - Chairman & CEO James P. Minicucci - Senior VP & GM of Personal Care William C.
Compared to Estimates, Ashland (ASH) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Ashland (ASH) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
